Crossmark

Retro-inversion follicle-stimulating hormone peptide-modified nanoparticles for delivery of PDK2 shRNA against chemoresistant ovarian cancer by switching glycolysis to oxidative phosphorylation

Crossref DOI link: https://doi.org/10.1186/s12645-022-00129-8

Published Online: 2022-07-25

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Meng

Du, Ming

Qi, Xingling

Wang, Yumeng

Li, Guiling

Xu, Congjian

Zhang, Xiaoyan
Funding

Funding for this research was provided by:

Shanghai Medical Center of Key Programs for Female Reproductive Diseases (2017ZZ01016)

National Natural Sciences Foundation of China (82172747)
License Information

Text and Data Mining valid from 2022-07-25

Version of Record valid from 2022-07-25
More Information

Article History

Received: 8 March 2022

Accepted: 11 July 2022

First Online: 25 July 2022

Declarations

:

: The study was approved by the Ethics Committee at Obstetrics and Gynecology Hospital of Fudan University and the Institutional Animal Care and Use Committee of SLAC.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below